Preparation method and application of nitrofurazone metabolite sem derivatized hapten and artificial antigen
A technology of nitrofurazone and artificial antigen, applied in the field of immunochemistry, can solve the problem that the SEM hapten cannot completely retain the characteristic structure of the competitor, and achieve the effect of enhanced immunogenicity, high sensitivity and strong specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] Such as Figure 1-5 As shown, the nitrofurazone metabolite SEM derivatized hapten of the present embodiment 1 is prepared by the following method, and the steps are as follows:
[0050] (a') Dissolve 2.0g (ie 7.1mmol) of compound I in 10ml of ethanol, adjust the pH value of compound I's ethanol solution to 10-12 through 6mol / L lithium hydroxide solution, and react at room temperature for 15-26h , add 40ml of purified water, adjust the pH value of the resulting solution to 4-5 with 1M dilute hydrochloric acid, filter, and dry to obtain 1.1g of compound II.
[0051] ESI-MS: 167[M-CH2CH2CH2COOH-1], 252[M-1], 288[M+2H2O-1], 315[2×167-H2O-1], 505[2M-1], 537[2M +MeOH-1];
[0052] 1H NMR (600MHz, CDCl 3 , TMS): δ10.50(s, 1H), 8.20(d, 1H), 7.35(d, 1H), 7.15-7.19(dd, 1H), 4.23(t, 2H), 2.66(t, 2H), 2.26 (m, 2H).
[0053] (b') Dissolve 0.5g (i.e. 2.0mmol) of compound II in 10ml of methanol, add 0.18g (i.e. 2.4mmol) of nitrofurazone metabolite SEM, react at 60-70°C for 2h, aft...
Embodiment 2
[0057] Example 2 is an artificial antigen of nitrofurazone metabolites. The artificial antigen includes an immunogen and a coating source. The difference between the two is that the types of carrier proteins coupled during the preparation process are different. For the prepared hapten, the carrier protein is bovine serum albumin (BSA); the coating source is the hapten prepared in Example 1, and the carrier protein is ovalbumin (OVA).
[0058] The coating former of the nitrofurazone metabolite of present embodiment 2 is prepared by the following method, and its steps are as follows in sequence:
[0059] (1) Take 10.0 mg of the hapten of Example 1, dissolve it in 0.5 ml of dimethylformamide (DMF), stir well, add 8.0 mg of carbodiimide (EDC) and 6.0 mg of N-hydroxysuccinate imide (NHS), stirred at room temperature for 4 hours, the hapten activated ester can be obtained;
[0060] (2) Weigh 43.0mg of ovalbumin (OVA), fully dissolve it in 4ml of PBS solution with a concentration of...
Embodiment 3
[0072] The monoclonal antibody of the nitrofurazone metabolite of present embodiment 3 is prepared by the following method, and its steps are:
[0073] After emulsifying the immunogenic formula (III)-BSA prepared in Example 2 with an equal volume of Freund's adjuvant, immunize BALB / C mice. The immunization dose for each mouse was 50-100 μg, and the immunization interval was 3 weeks. After 3 times of immunization, the blood of the tail vein of the mice was collected to detect the serum titer. If the antibody titer does not reach 60,000, booster immunization is required. After the antibody titer no longer rises, subcutaneous booster immunization is performed with 100 μg of immunogen, and the splenocytes of the mouse are fused with SP20 cells 5 days later. The fused cells were selected in HAT medium, and after 5 days, the complete medium was replaced with HAT medium for culture. Use ELISA to detect the cell supernatant, and carry out the limited dilution clone culture of the cel...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com